BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32027454)

  • 21. Aurora A selective inhibitor MLN8237 suppresses the growth and survival of HTLV-1-infected T-cells in vitro.
    Tomita M; Mori N
    Cancer Sci; 2010 May; 101(5):1204-11. PubMed ID: 20180813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compound C/Dorsomorphin: Its Use and Misuse as an AMPK Inhibitor.
    Dasgupta B; Seibel W
    Methods Mol Biol; 2018; 1732():195-202. PubMed ID: 29480476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-adult T-cell leukemia effects of a novel synthetic retinoid, Am80 (Tamibarotene).
    Nakazato T; Okudaira T; Ishikawa C; Nakama S; Sawada S; Tomita M; Uchihara JN; Taira N; Masuda M; Tanaka Y; Ohshiro K; Takasu N; Mori N
    Cancer Sci; 2008 Nov; 99(11):2286-94. PubMed ID: 18771528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonate incadronate inhibits growth of human T-cell leukaemia virus type I-infected T-cell lines and primary adult T-cell leukaemia cells by interfering with the mevalonate pathway.
    Ishikawa C; Matsuda T; Okudaira T; Tomita M; Kawakami H; Tanaka Y; Masuda M; Ohshiro K; Ohta T; Mori N
    Br J Haematol; 2007 Feb; 136(3):424-32. PubMed ID: 17233845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An IκB kinase 2 inhibitor IMD-0354 suppresses the survival of adult T-cell leukemia cells.
    Uota S; Zahidunnabi Dewan M; Saitoh Y; Muto S; Itai A; Utsunomiya A; Watanabe T; Yamamoto N; Yamaoka S
    Cancer Sci; 2012 Jan; 103(1):100-6. PubMed ID: 21951590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TAS-116 (pimitespib), a heat shock protein 90 inhibitor, shows efficacy in preclinical models of adult T-cell leukemia.
    Ikebe E; Shimosaki S; Hasegawa H; Iha H; Tsukamoto Y; Wang Y; Sasaki D; Imaizumi Y; Miyazaki Y; Yanagihara K; Hamaguchi I; Morishita K
    Cancer Sci; 2022 Feb; 113(2):684-696. PubMed ID: 34794206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WRN-targeted therapy using inhibitors NSC 19630 and NSC 617145 induce apoptosis in HTLV-1-transformed adult T-cell leukemia cells.
    Moles R; Bai XT; Chaib-Mezrag H; Nicot C
    J Hematol Oncol; 2016 Nov; 9(1):121. PubMed ID: 27829440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T-cell leukemia.
    Ishikawa C; Mori N
    Eur J Haematol; 2024 Jul; 113(1):99-109. PubMed ID: 38558052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia.
    Watanabe M; Ohsugi T; Shoda M; Ishida T; Aizawa S; Maruyama-Nagai M; Utsunomiya A; Koga S; Yamada Y; Kamihira S; Okayama A; Kikuchi H; Uozumi K; Yamaguchi K; Higashihara M; Umezawa K; Watanabe T; Horie R
    Blood; 2005 Oct; 106(7):2462-71. PubMed ID: 15956280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-adult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol.
    Ishikawa C; Tafuku S; Kadekaru T; Sawada S; Tomita M; Okudaira T; Nakazato T; Toda T; Uchihara JN; Taira N; Ohshiro K; Yasumoto T; Ohta T; Mori N
    Int J Cancer; 2008 Dec; 123(11):2702-12. PubMed ID: 18798263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma.
    Narita T; Ishida T; Ito A; Masaki A; Kinoshita S; Suzuki S; Takino H; Yoshida T; Ri M; Kusumoto S; Komatsu H; Imada K; Tanaka Y; Takaori-Kondo A; Inagaki H; Scholz A; Lienau P; Kuroda T; Ueda R; Iida S
    Blood; 2017 Aug; 130(9):1114-1124. PubMed ID: 28646117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C7a, a biphosphinic cyclopalladated compound, efficiently controls the development of a patient-derived xenograft model of adult T cell leukemia/lymphoma.
    Guimaraes-Correa AB; Crawford LB; Figueiredo CR; Gimenes KP; Pinto LA; Grassi MFR; Feuer G; Travassos LR; Caires ACF; Rodrigues EG; Marriott SJ
    Viruses; 2011 Jul; 3(7):1041-1058. PubMed ID: 21994769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir.
    Dewan MZ; Uchihara JN; Terashima K; Honda M; Sata T; Ito M; Fujii N; Uozumi K; Tsukasaki K; Tomonaga M; Kubuki Y; Okayama A; Toi M; Mori N; Yamamoto N
    Blood; 2006 Jan; 107(2):716-24. PubMed ID: 16174765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arsenic trioxide induces apoptosis in HTLV-I infected T-cell lines and fresh adult T-cell leukemia cells through CD95 or tumor necrosis factor alpha receptor independent caspase activation.
    Ishitsuka K; Ikeda R; Utsunomiya A; Uozumi K; Hanada S; Suzuki S; Takeuchi S; Takatsuka Y; Takeshita T; Ohno N; Arima T
    Leuk Lymphoma; 2002 May; 43(5):1107-14. PubMed ID: 12148893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of PKC-δ in HTLV-1-infected T cells.
    Mori N; Ishikawa C; Senba M
    Int J Oncol; 2015 Apr; 46(4):1609-18. PubMed ID: 25625567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic abnormalities in adult T-cell leukemia/lymphoma and induction of specific leukemic cell death using photodynamic therapy.
    Oka T; Mizuno H; Sakata M; Fujita H; Yoshino T; Yamano Y; Utsumi K; Masujima T; Utsunomiya A
    Sci Rep; 2018 Oct; 8(1):14979. PubMed ID: 30297858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of human T-cell leukemia virus type I-infected cells to humanized anti-CD30 monoclonal antibodies in vitro and in vivo.
    Maeda N; Muta H; Oflazoglu E; Yoshikai Y
    Cancer Sci; 2010 Jan; 101(1):224-30. PubMed ID: 19799612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
    Mori N; Matsuda T; Tadano M; Kinjo T; Yamada Y; Tsukasaki K; Ikeda S; Yamasaki Y; Tanaka Y; Ohta T; Iwamasa T; Tomonaga M; Yamamoto N
    J Virol; 2004 May; 78(9):4582-90. PubMed ID: 15078940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia.
    Tsumuraya T; Ishikawa C; Machijima Y; Nakachi S; Senba M; Tanaka J; Mori N
    Biochem Pharmacol; 2011 Mar; 81(6):713-22. PubMed ID: 21219881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of caveolin-1 in adult T-cell leukemia.
    Sawada S; Ishikawa C; Tanji H; Nakachi S; Senba M; Okudaira T; Uchihara JN; Taira N; Ohshiro K; Yamada Y; Tanaka Y; Uezato H; Ohshima K; Sasai K; Burgering BM; Duc Dodon M; Fujii M; Sunakawa H; Mori N
    Blood; 2010 Mar; 115(11):2220-30. PubMed ID: 20061557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.